Globus Medical to announce Q2 results on August 6

0 min read | Published on 17 Jul 2026, 02:24 AM |Updated on 17 Jul 2026, 02:24 AM

Reviewed by

Jubin VScanX News Team

Key Highlights

Globus Medical, Inc. is set to release its second quarter financial results for the period ended June 30, 2026, on August 6, 2026. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results, accessible via webcast or telephone with prior registration.

*this image is generated using AI for illustrative purposes only.

Globus Medical, Inc. will announce its financial results for the second quarter ended June 30, 2026, after the market close on August 6, 2026. The announcement will provide details on the company's performance for the period, with stakeholders able to access the release on the Globus Medical website.

Following the release, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants can access the live webcast via the Investors page of the company's website. Telephone participants must register in advance to receive the dial-in number and unique passcode.

The audio archive of the conference call will be available after the event on the Investors page of the Globus Medical website. The company operates as a musculoskeletal technology firm focusing on spine, orthopedic trauma, and joint reconstruction.

Key Event Details

Event	Date	Time
Q2 Earnings Release	August 6, 2026	After market close
Conference Call	August 6, 2026	4:30 p.m. ET

Access Information

Webcast: Available at https://www.investors.globusmedical.com/news-events/events-webcasts
Telephone Registration: Advance registration is required to obtain dial-in details.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What market trends in spine and orthopedic trauma might influence Globus Medical's Q2 performance?

How could the company's focus on joint reconstruction impact its revenue growth in the upcoming quarters?

What strategic initiatives is Globus Medical likely to highlight during the conference call to drive future growth?

Truist maintains Buy on Globus Medical, cuts target to $100

0 min read | Published on 09 Jul 2026, 10:17 PM |Updated on 16 Jul 2026, 11:42 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

Truist Securities analyst Richard Newitter maintained a Buy rating on Globus Medical but lowered the price target to $100 from $115. The adjustment reflects a revised valuation benchmark for the NYSE-listed stock.

*this image is generated using AI for illustrative purposes only.

Truist Securities analyst Richard Newitter has maintained a Buy rating for Globus Medical while lowering the price target to $100 from $115. The adjustment reflects a revised valuation benchmark for the stock, which trades on the NYSE under the ticker GMED. This follows a previous rating action by RBC Capital, which had also adjusted its target to $115 while maintaining an Outperform rating.

Rating and Valuation

The Buy rating indicates that the firm expects the stock to perform better than the market average. The reduction in the price target suggests a recalibration of the company's near-term valuation prospects.